Stem Cells

Permanent URI for this community

https://hdl.handle.net/1805/692

Since the announcements that human stem cells had been isolated and cultured, the United States has witnessed unprecedented public discussion and debate about the ethical and legal issues raised by this research.
Eric M. Meslin, PhD, & Sarah E. Martin, MA. From Stem to Stern: A Brief Review of Ethical Issues in the Stem Cell Debate. NeoReviews. Vol.4 No.7 2003 e187.

Central Indiana Bioethics Portal website.

News

Comments or questions:
Amy J. Hatfield, M.L.S.,
IU School of Medicine
ajhatfie@iupui.edu

Browse

Browsing Stem Cells by Title

Now showing 1 - 10 of 50
  • Thumbnail Image
    Item
    Alternative sources of human pluripotent stem cells
    (2005-05) President’s Council on Bioethics (U.S.)
    Discusses the following questions for four sources of stem cells: (1.) "Is it ethically sound?", (2.) "Is is scientifically sound?", (3.) "Is it 'realistic'?".
  • Thumbnail Image
    Item
    Can routine commercial cord blood banking be scientifically and ethically justified?
    (Public Library of Science, 2005-02) Fisk, Nicholas
    Debates the issue of whether or not cord blood should be saved on a regular basis.
  • Thumbnail Image
    Item
    Emerging regulatory issues for human stem cell medicine
    (ESRC Genomics Network, 2005-02) Liddell, Kathleen; Wallace, Susan
    Discusses the issues involved in regulating the products of stem cell research in the United Kingdom.
  • Thumbnail Image
    Item
    Ethical issues in human stem cell research. Volume I. Report and recommendations of the National Bioethics Advisory Commission.
    (1999-09) United States. National Bioethics Advisory Commission
    Clinton administration report on the bioethical issues of stem cell research.
  • Thumbnail Image
    Item
    Ethical issues in human stem cell research. Volume II. Commissioned papers.
    (2000-01) United States. National Bioethics Advisory Commission
    Clinton administration perspectives of the bioethical issues of stem cell research. Contains ten papers.
  • Thumbnail Image
    Item
    Ethical issues in human stem cell research. Volume III. Religious perspectives.
    (2000-06) United States. National Bioethics Advisory Commission
    Viewpoints of religious scholars and leaders on the ethical issues of stem cell research. Contains ten articles, referred to as "testimonies".
  • Thumbnail Image
    Item
    A history of patenting life in the United States with comparative attention to Europe and Canada: a report to the European Group on Ethics in Science and New Technologies
    (Office for Official Publications of the European Communities, 2002-01-12) Kevles, Daniel
    Discusses the ethical issues of patenting life forms such as plants and microorganisms, with the wider implications of patenting human stem cell technology.
  • Thumbnail Image
    Item
    Human cloning and embryonic stem cell research after Seoul. [Additional information (1)]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Thumbnail Image
    Item
    Human cloning and embryonic stem cell research after Seoul. [Additional information (2)]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Thumbnail Image
    Item
    Human cloning and embryonic stem cell research after Seoul. [Battey]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Battey, James F.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
Although these works may be freely accessible on the World Wide Web and may not include any statement about copyright, the U.S. Copyright Act nevertheless provides that such works are protected by copyright. Users must assume that works are protected by copyright until they learn otherwise.